PROBIOTIX HEALTH LS-05 (X90) — Defensive Interval Ratio

Latest as of June 2025: 574 days

PROBIOTIX HEALTH LS-05 (X90) has a Defensive Interval Ratio of 574 days as of June 2025. Defensive assets of €846.00K (cash €-, short-term investments €-, receivables €846.00K) cover 574 days of daily cash needs of €1.47K/day. See X90 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

574 days
Days of operational coverage

Defensive Assets

€846.00K
Cash + ST Investments + Receivables

Daily Cash Need

€1.47K
Current Liabilities ÷ 365

Current Liabilities

€538.00K
EUR

PROBIOTIX HEALTH LS-05 Defensive Interval Ratio (2022–2024)

This chart shows how PROBIOTIX HEALTH LS-05's Defensive Interval Ratio has evolved across 3 annual periods from 2022 to 2024. As of June 2025, the ratio stands at 574 days, meaning defensive assets of €846.00K can fund 574 days of operations without new revenue. See X90 net asset quality index to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for PROBIOTIX HEALTH LS-05 (2022–2024)

The table below presents the year-by-year Defensive Interval Ratio for PROBIOTIX HEALTH LS-05 from 2022 to 2024, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see X90 market cap.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 265 days €141.00K €531.51/day €- €- ▲ +134 days
2023 131 days €203.00K €1.55K/day €- €- ▼ -341 days
2022 472 days €351.79K €745.32/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)